Approval · Notice of Compliance 19317 · 2017
VEMLIDY: Notice of Compliance 19317
Issued May 17, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 19317
- Date
- May 17, 2017
- Company
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| VEMLIDY | 02464241 | Marketed |
Medicinal ingredients
- TENOFOVIR ALAFENAMIDE HEMIFUMARATE 25 MG per TAB